Статья
Кардиологический шоковый центр — следующая ступень в лечении кардиогенного шока
Ключевой в достижении значимого снижения смертности пациентов с инфарктом миокарда (ИМ) стала организация широкой сети специализированных ЧКВ-центров, оказывающих помощь пациентам с острым коронарным синдромом (ОКС) в режиме 24/7 в соответствии с четкими протоколами. Тем не менее, на сегодняшний день внутригоспитальная смертность пациентов с ИМ, осложненным кардиогенным шоком (КШ), остается крайне высокой и составляет в среднем 50%. Создание системы высокоспециализированных центров представляется наиболее перспективной возможностью улучшить прогноз пациентов с КШ. В статье рассматривается мировой научный и клинический опыт организации кардиологических шоковых центров, особенности их внутренней структуры, а также административно-логистические аспекты работы всей системы в целом.
1. Anderson ML, Peterson ED, Peng SA, et al. Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification. A Report From NCDR. Circulation: Cardiovascular Quality and Outcomes. 2013;6:708-15. doi:10.1161/CIRCOUTCOMES.113.000262.
2. Hochman JS, Sleeper LA, Godfrey E, et al. SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/ CABG–trial design. American Heart Journal. 1999;137(2):313-21. doi:10.1053/hj.1999.v137.95352.
3. Thiele H, Zeymer U, Neumann F‐J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-96. doi:10.1056/NEJMoa1208410.
4. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2017;69(3):278-87. doi:10.1016/j.jacc.2016.10.022.
5. Seyfarth M, Sibbing D, Bauer I, et al. A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction. Journal of the American College of Cardiology. 2008;52(19):1584-8. doi:10.1016/j.jacc.2008.05.065.
6. Masoudi FA, Ponirakis A, de Lemos JA, et al. Trends in U.S. cardiovascular care. 2016 report from 4 ACC National Cardiovascular Data Registries. Journal of American College of Cardiology. 2017;69:1427-50. doi:10.1016/j.jacc.2016.12.005.
7. Basir MB, Schreiber T, Dixon S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Catheterization and Cardiovascular Interventions. 2017;91(3):454-61. doi:10.1002/ccd.27427.
8. O’Neill WW, Grines C, Schreiber T, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella® device. American Heart Journal. 2018;202:33-8. doi:10.1016/j.ahj.2018.03.024.
9. O’Neil WW, Schreiber T, Wohns DHW, et al. The Current Use of Impella® 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry. Journal of Interventional Cardiology. 2013;27(1):1-11. doi:10.1111/joic.12080.
10. Basir MB, Schreiber TL, Grines CL, et al. Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. The American Journal of Cardiology. 2017;119(6):845-51. doi:10.1016/j.amjcard.2016.11.037.
11. Shaefi S, O’Gara B, Kociol RD, et al. Effect of Cardiogenic Shock Hospital Volume on Mortality in Patients With Cardiogenic Shock. Journal of the American Heart Association. 2015;4(1):1462-2. doi:10.1161/jaha.114.001462.
12. Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. European Heart Journal. 2018;39(13):1065-74. doi:10.1093/eurheartj/ehy004.
13. Kontos MC, Wang Y, Chaudhry SI, et al. Lower Hospital Volume Is Associated With Higher In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Report From the NCDR. Circulation: Cardiovascular Quality and Outcomes. 2013;6(6):659-67. doi:10.1161/circoutcomes.113.000233.
14. Kutty RS, Jones N, Moorjani N. Mechanical Complications of Acute Myocardial Infarction. Cardiology Clinics. 2013;31(4);519-31. doi:10.1016/j.ccl.2013.07.004.
15. Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. European Heart Journal. 2014;Aug 14;35(31):2060-8. doi:10.1093/eurheartj/ehu248.
16. Bonnefoy-Cudraz E, Bueno H, Casella G, et al. Editor’s Choice — Acute Cardiovascular Care Association Position Paper on Intensive Cardiovascular Care Units: An update on their definition, structure, organisation and function. European Heart Journal: Acute Cardiovascular Care. 2018;7(1):80-95. doi:10.1177/2048872617724269.
17. Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction. 2018;44(6):760-73. doi:10.1007/s00134-018-5214-9.
18. Lauridsen MD, Gammelager H, Schmidt M, et al. Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. 2015;19:452. doi:10.1186/s13054-015-1170-8.
19. Thiele H, Akin I, Sandri M, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. 2017;377(25):2419-32. doi:10.1056/NEJMoa1710261.
20. Basir MB, Kapur NK, Patel K, et al. Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative. Catheterization and Cardiovascular Interventions. 2019;93(7):1173-83. doi:10.1002/ccd.28307.
21. Tehrani B, Truesdell A, Singh R, et al. Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry): Observational and Retrospective Study. JMIR Res Protoc. 2018;7(6):e160. doi:10.2196/resprot.9761.
22. Truesdell AG, Tehrani B, Singh R, et al. ‘Combat’ Approach to Cardiogenic Shock. Interv Cardiol. 2018;13(2):81-6. doi:10.15420/icr.2017:35:3.
23. Rab T, Ratanapo S, Kern KB, et al. Cardiac Shock Care Centers. Journal of the American College of Cardiology. 2018;72(16):1972-80. doi:10.1016/j.jacc.2018.07.074.
24. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119-77. doi:10.1093/eurheartj/ehx393.
25. Tehrani B, Truesdell AG, Sherwood MW, et al. Standardized Team-Based Care for Cardiogenic Shock. Journal of the American College of Cardiology. 2019;72(13):1659-69. doi:10.1016/j.jacc.2018.12.084.